Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

Denali Therapeutics DNLI has performed well in the past 12 months amid a volatile market. Shares of the company have gained ...

DANCING On Ice star Chelsee Healey has revealed her biggest fear for the ITV skating show. It comes as the Hollyoaks actress, 36, takes on her "first challenge" since giving birth to her second ...

Gov. Maura Healey has proposed a $425 million spending bill to keep Massachusetts' emergency shelter system running through the end of fiscal year 2025. The plan unveiled recently would drain ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from ...

Denali Therapeutics Inc. (NASDAQ:DNLI) recently reported results from its phase 2/3 HEALEY ALS Platform Trial using DNL343 for the treatment of patients with Amyotrophic Lateral Sclerosis [ALS].

DNL343 and fosigotifator are made to activate the ISR pathway protein eIF2B, but both failed to slow ALS progression in the HEALEY trial.

Governor Maura Healey is requesting a moment of silence on Thursday morning to honor the life of former President Jimmy Carter, who died late last month. President Joe Biden declared Jan. 9 a ...

“We hope that this AI platform will provide a framework to help doctors and patients decide if the results of a clinical trial can apply to individual patients,” Parikh says. “Furthermore, this study ...

Gov. Maura Healey signed two major healthcare reform bills Wednesday — one that looks to increase hospital oversight in the wake of the Steward Health Care meltdown and another that attempts to ...